JPMorgan on Hindalco
Maintained ‘Overweight’ with a price target at Rs 270.
In line quarter, attractive balance sheet and downstream business.
Aleris Completion key catalyst.
Valuations at 5.2x EV/Ebitda substantially below mid-cycle levels.